Back to today’s briefing

Story perspectives

AI Saliva Test Revolutionizes Cancer Treatment and Safety

5/2/2025

38 7

Summary

Story summary

A groundbreaking study from Virginia Tech reveals that an AI-driven saliva test can pinpoint cancer patients at heightened risk for severe side effects from the chemotherapy drug 5-fluorouracil (5-FU). By identifying genetic mutations that influence drug metabolism, this innovative approach paves the way for tailored treatment plans, enhancing patient safety and outcomes. Results were unveiled at the 2025 ASCO Gastrointestinal Cancers Symposium.

1 of 1

Story summary

A groundbreaking study from Virginia Tech reveals that an AI-driven saliva test can pinpoint cancer patients at heightened risk for severe side effects from the chemotherapy drug 5-fluorouracil (5-FU). By identifying genetic mutations that influence drug metabolism, this innovative approach paves the way for tailored treatment plans, enhancing patient safety and outcomes. Results were unveiled at the 2025 ASCO Gastrointestinal Cancers Symposium.